Healthcare & Life Sciences
MinervaX
Denmarkminervax.com
MinervaX is a series c plus startup based in Denmark. 1 investor tracked.
Activeseries-c-plus
series-c-plus
Stage
2018
Founded
4
Investors
About MinervaX
MinervaX is a company founded in 2018 headquartered in Denmark. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 4 investors associated with the company.
MinervaX is a clinical-stage biotechnology company focused on developing a novel vaccine against Group B Streptococcus (GBS). This vaccine aims to protect newborns from GBS infections.
Explore MinervaX's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.